Therapeutic options and innovative approaches in inoperable locally advanced non small-cell lung cancer (stage IIIB);Strategies therapeutiques recentes et voies de recherche actuelles dans les cancers du poumon inoperables (stade IIIB) non a petites cellules

Bulletin du Cancer

Volumn 84, Issue 4, 1997, Pages 413-419

  Le Cesne, Axel ^a   Arriagada, Rodrigo ^a   Grunenwald, Dominique ^b   Baldeyrou, Pierre ^b   Girard, Philippe ^b   Bretel, Jean Jacques ^a   Le Chevalier, Thierry ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b INSTITUT MUTUALISTE MONTSOURIS   (France)

Author keywords

biotherapy; chemotherapy; non small cell lung cancer; radiotherapy; stage IIIB

Indexed keywords

ANTINEOPLASTIC AGENT; CANCER VACCINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOKINE; DOCETAXEL; ETOPOSIDE; GEMCITABINE; IRINOTECAN; LOMUSTINE; NAVELBINE; PACLITAXEL; VINBLASTINE SULFATE; VINDESINE; RECOMBINANT PROTEIN;

CLINICAL TRIAL; HUMAN; LUNG NON SMALL CELL CANCER; META ANALYSIS; REVIEW; CANCER STAGING; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENE THERAPY; LUNG CARCINOMA; LUNG TUMOR; METASTASIS; MORTALITY; PATHOLOGY; PROGNOSIS; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SURVIVAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, BRONCHOGENIC; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; GENE THERAPY; HUMANS; LUNG NEOPLASMS; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY DOSAGE; RECOMBINANT PROTEINS; SURVIVAL ANALYSIS;

EID: 0031113301     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Bartecchi CE, Mackenzie TD, Schrier RW. The human costs of tobacco use (first of two parts). N Engl J Med 1994; 330: 907-12.
2. Mountain CF. A new international staging system for lung cancer. Chest 1986; 89: 225-33.
3. Green MR. Unresectable stage III non small cell lung cancer: lessons and directions from clinical trial research. J Natl Cancer Inst 1991; 83: 382-3.
4. Feld R, Arriagada R, Ball DL, et al. Prognostic factors in non small cell lung cancer. Lung Cancer 1991; 7: 3-5.
5. Roswit B, Patno ME, Rapp R, et al. The survival of patients with inoperable lung cancer. A large-scale randomized study of radiation therapy versus placebo. Radiology 1968; 90: 688-97.
6. Perez CA, Stanley K, Rubin P, et al. A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat cell carcinoma of the lung. Cancer 1980; 45: 2744-53.
7. Damstrup L, Skovgaard Poulsen H. Review of the curative role of radiotherapy in the treatment of non small cell lung cancer. Lung Cancer 1994; 11: 153-78.
8. Kaasa S, Thorud E, Host H, et al. A randomized study evaluating radiotherapy versus chemotherapy in patients with inoperable non small cell lung cancer. Radiat Oncol 1988; 11: 7-13.
9. Crino L, Maranzano E, Meacci L, et al. Induction chemotherapy plus high dose radiotherapy versus radiotherapy alone in locally advanced unresectable non small cell lung cancer. Ann Oncol 1993; 4: 847-51.
10. Dillman O, Seagren SL, Propert KJ, et al. A randomized trial of induction chemotherapy plus high dose radiation versus radiation alone in stage III non small cell lung cancer. New Engl J Med 1990; 323: 940-8.
11. Le Chevalier T, Arriagada R, Quoix E, et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in non resectable NSCLC: first analysis of a randomized trial in 333 patients. J Natl Cancer Inst 1991; 83: 417-23.
12. Sause WT, Scott C, Taylor S. Radiation therapy oncology group (RTOG) 88-08 and Eastern cooperative oncology groupe (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non small cell lung cancer. J Natl Cancer Inst 1995; 87: 198-205.
13. Non Small Cell Lung Cancer Collaborative Group. Chemotherapy in non small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. Br J Med 1995; 311: 899-909.
14. Perez CA, Pajak TF, Rubin P, et al. Long term observations of the paterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Cancer 1987; 59: 1874-81.
15. Kramar A, Arriagada R. Analysizing local and distant recurrences. J Clin Oncol 1990; 8: 2086-7.
16. Holsti L, Mattson K. A randomized study of split course radiotherapy of lung cancer: long term results. Int J Radiat Oncol Biol Phys 1980; 6: 977-81.
17. Slawson RG, Salazar OM, Poussin-Rosillo H, et al. Once a week versus conventional daily radiation treatment for lung cancer: final report. Int J Radiat Oncol Biol Phys 1988; 15: 61-8.
18. Sounders MI, Dische S, Grosch EJ, et al. Experience with CHART. Int J Radiat Oncol Biol Phys 1991; 21: 871-8.
19. Armstrong J, Burman C, Leibel S, et al. Conformal three dimensional treatment planning may improve the therapeutic ratio of high dose radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys 1991; 21: 146-52.
20. McDonald S, Chang AY, Rubin P, et al. Combined beta seron (Recombinant Human Interferon beta) and radiation for inoperable non small cell lung cancer. Int J Radiat Oncol Biol Phys 1993; 27: 613-9.
21. Perez CA, Bauer M, Emami B, et al. Thoracic irradiation with or without levamisole (NSC 17 70 23) in unresectable non small cell carcinoma of the lung: a phase III randomized trial of RTOG. Int J Radiat Oncol Biol Phys 1988; 15: 1337-46.
22. Simpson JR, Bauer M, Wasserman T, et al. Large fraction irradiation with or without nisonidazole in advanced non-oat cell carcinoma of the lung: a phase III randomized trial of the RTOG. Int J Radiat Oncol Biol Phys 1987; 13: 861-7.
23. Dewit L. Combined treatment of radiation and cis-dichlorodiammine-platinum: a review of experimental and clinical data. Int J Radiat Oncol Biol Phys 1987; 13: 403-6.
24. Blancke C, Ansari R, Mantraverdi R, et al. Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non small cell lung cancer: a Hoasier Oncology Group Protocol. J Clin Oncol 1995; 13: 1425-9.
25. Schaake-Koning C, Van Den Bogaert W, Dalesio O. Effects of concomitant cisplatin and radiotherapy on inoperable non small cell lung cancer. New Engl J Med 1992; 326: 324-30.
26. Soresi E, Clerici M, Grilli R, et al. A randomized clinical trial comparing radiation therapy versus radiation therapy plus cis-dichlorodiammine platinum (II) in the treatment of locally advanced non small cell lung cancer. Sem Oncol 1988; 15: 20-5.
27. Trovo MG, Minatel E, Franchin G, et al. Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non small cell lung cancer. Int J Radiat Oncol Biol Phys 1992; 24: 11-5.
28. Shaw EG, McGinnis WL, Jett R, et al. Pilot study of accelerated hyperfractionated thoracic radiation therapy plus concomitant etoposide and cisplatin chemotherapy in patients with unresectable stage III non small cell carcinoma of the lung. J Natl Cancer Inst 1993; 85: 321-3.
29. Le Chevalier T, Brisgand D, Douillard J, et al. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non small cell lung cancer: results of a European multicenter trial including 612 patients. J Clin Oncol 1994; 12: 360-7.
30. Bonomi P. Brief overview of combination chemotherapy in non small cell lung cancer. Semin Oncol 1986; 13: 89-91.
31. Le Chevalier T. Chimiothérapie des cancers bronchiques non à petites cellules. Presse Med 1996; 25: 1699-703.
32. Bunn PA. New drug combinations in the treatment of advanced non small cell (NSCLC) and small cell (SCLC) lung cancer. Educational book. ASCO, 32nd annual meeting, Philadelphia: Pennsylvania, May 18-21, 1996.
33. Fleck J, Camargo J, Godoy D, et al. Chemoradiation therapy versus chemotherapy alone as a neoadjuvant for stage III non small cell lung cancer. Preliminary report of a phase III prospective randomized trial. Proc Am Soc Clin Oncol 1993; 12: 1108.
34. Rosell R, Gomez-Codina J, Camps C, et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non small cell lung cancer. New Engl J Med 1994; 330: 153-8.
35. Albain KS, Rusch VW, Crowley JJ, et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non small cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 1995; 13: 1880-92.
36. Grunenwald D, Le Chevalier T, Arriagada R, et al. Surgical resection of stage IIIB non small cell lung cancer (NSCLC) after concomitant induction chemo-radiotherapy. Preliminary results of Pilot study. Proc Am Soc Clin Oncol 1995; 14: 1027.
37. Oppenheim MH, Lotze MT. Interleukine-2: solid-tumor therapy. Oncology 1994; 51: 154-69.
38. Vokes E, Hochster H, Lotze M, et al. Recombinant human IL4 in non small cell lung cancer: results of a phase II investigation. Proc Am Soc Clin Oncol 1994; 13: 1107.
39. Fisbein GE. Immunotherapy of lung cancer. Semin Oncol 1993; 20: 351-8.
40. Brichard VG. New tumor antigens recognized by T cells. Curr Op Immunol 1995; 7: 674-81.
41. Dranoff G, Jaffee E, Lazenby A, et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific and long-lasting antitumor immunity. Proc Natl Acad Sci USA 1993; 90: 3539-43.
42. Carbone DP, Minna JD. The molecular genetics of lung cancer. Science 1989; 246: 491-4.
43. Roth J. Gene replacement for cancer. 6th International Congress on Anti-Cancer Treatment, Paris: 1996, 60.
44. Soo Lin J, Yoon A, Kalapurakal SK, et al. Expression of p53 oncoprotein in non small cell lung cancer: a favorable pronostic factor. J Clin Oncol 1995; 13: 1893-903.
45. Tursz T, Le Cesne A, Baldeyrou P, et al. Recombinant adenoviral-mediated gene transfer: preliminary report of a phase I study in lung cancer patients. J Natl Cancer Inst 1996; 88: 1857-63.